Over 95% of potential anti-cancer drugs failed in clinical trials despite vast investment to bring the drug to market. The last decade of cancer research has also seen numerous advances aimed at ...

It is expected that more accurate drug effect prediction will be possible with the development of 'organoid' which improves performance. Professor Bang Seung-min and Lim Gar-ram of the Department ...

These and other 3D organoid models developed by Predictive Oncology substantially complement its AI-driven 2D platform and 3D spheroids, which utilize human tumor samples to accelerate drug ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...

Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- ...

According to the market research firm Research and Markets, the patient-derived organoid market size is expected to grow from $1 billion (approximately 1.3678 trillion won) in 2024 to $3.3 billion ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...